Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FDA Approves New Shingles Vaccine
New vaccine, said to be more effective, is second approved for U.S. market. (Source: WebMD Health)
Source: WebMD Health - October 23, 2017 Category: Consumer Health News Source Type: news

Health Highlights: Oct. 23, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: New Shingles Vaccine Approved by FDA A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 23, 2017 Category: General Medicine Source Type: news

GSK wins U.S. shingles vaccine approval, UK nod for gene therapy
LONDON (Reuters) - GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year. (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Improved shingles vaccine approved
An improved shingles vaccine has been approved by the U.S. Food and Drug Administration and the?Centers for Disease Control and Prevention's Advisory Committee is expected to vote on the recommendation the week of Monday Oct. 23. The new vaccine, which reportedly prevents shingles in 90 percent of people, is recommended for adults 50 and over. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 23, 2017 Category: Databases & Libraries Source Type: news

FDA Approves New Herpes Zoster Vaccine (FREE)
By the Editors The FDA has approved a second vaccine to prevent herpes zoster in adults aged 50 and older, the manufacturer announced on Friday. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 23, 2017 Category: Primary Care Source Type: news

FDA approves better vaccine against painful shingles virus
US regulators approve a new, more effective vaccine to prevent painful shingles caused by the chickenpox virus (Source: ABC News: Health)
Source: ABC News: Health - October 20, 2017 Category: Consumer Health News Tags: Health Source Type: news

GlaxoSmithKline adult shingles vaccine wins U.S. approval
(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles
London UK 20 October 2017 -- GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

GSK ’s Shingrix receives approval in Canada to prevent shingles
GlaxoSmithKline ’s (GSK) non-live, recombinant sub-unit, adjuvanted vaccine Shingrix has received approval from Health Canada to prevent shingles (herpes zoster) in people aged 50 or older. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 15, 2017 Category: Pharmaceuticals Source Type: news

GSK Shingles Vaccine Shingrix Gets First Okay in Canada GSK Shingles Vaccine Shingrix Gets First Okay in Canada
Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥ 90% efficacy in clinical trials.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

GlaxoSmithKline's shingles vaccine gets approval in Canada
(Reuters) - Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Most Physicians Say Shingrix Important Development for Shingles Most Physicians Say Shingrix Important Development for Shingles
Although many primary care providers were unfamiliar with the shingles vaccine, they were impressed with it after they learned about it.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Shingles Quiz: Symptoms, Vaccine & Pictures
Title: Shingles Quiz: Symptoms, Vaccine& PicturesCategory: MedicineNet QuizCreated: 6/11/2010 12:00:00 AMLast Editorial Review: 9/19/2017 5:50:16 PM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 19, 2017 Category: Dermatology Source Type: news

FDA Advisers Recommend Approval of New Shingles Vaccine (FREE)
By the Editors An FDA advisory panel voted 11-0 on Wednesday in favor of approving the Shingrix herpes zoster vaccine for adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 14, 2017 Category: Primary Care Source Type: news

US FDA advisory committee votes for GSK ’s Shingrix to prevent shingles
The US Food and Drug Administration ’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted unanimously for GlaxoSmithKline’s (GSK) Shingrix (HZ/su) to prevent herpes zoster (shingles) in adults of 50 years of age and a… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news